Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-27
1996-04-09
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514307, 514309, 514311, 514312, 546 22, 546141, 546142, 546144, 546153, 546155, 546167, C07D40112, C07D21500, C07D21702, A61K 3147
Patent
active
055062407
ABSTRACT:
The invention relates to N-acyl-N-heterocyclylalkylamino acids of the formula ##STR1## The compounds and their pharmaceutically acceptable salts can be used as antihypertensives, agents for the treatment of glaucoma, or for increasing the flow of the retinal ocular fluid.
REFERENCES:
patent: 4006239 (1977-02-01), Mayer et al.
patent: 5096897 (1992-03-01), Boshagen et al.
patent: 5191092 (1993-03-01), Niewohner et al.
Derwent Abstract 54175r, 1970 of BE 745,065.
Derwent Abstract 91-254550, 1991, of EP 443,983.
European Patent Office Search Report Nov. 23, 1992.
Buhlmayer Peter
Schmidlin Tibur
Zbinden Paul
Ciba-Geigy Corporation
Davis Zinna N.
Fishman Irving
Ivy C. Warren
Kaiser Karen
LandOfFree
N-acyl-n-quinolinyl or isoquinounyl alkylamino acids composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acyl-n-quinolinyl or isoquinounyl alkylamino acids composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyl-n-quinolinyl or isoquinounyl alkylamino acids composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-139294